• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

莫法罗汀在不同物种肝细胞和肝微粒体中的代谢。与体内数据的比较以及对参与人体生物转化的细胞色素P450同工酶的评估。

Metabolism of mofarotene in hepatocytes and liver microsomes from different species. Comparison with in vivo data and evaluation of the cytochrome P450 isoenzymes involved in human biotransformation.

作者信息

Valles B, Schiller C D, Coassolo P, De Sousa G, Wyss R, Jaeck D, Viger-Chougnet A, Rahmani R

机构信息

Pharma Division, F. Hoffmann-La Roche, Basel, Switzerland.

出版信息

Drug Metab Dispos. 1995 Oct;23(10):1051-7.

PMID:8654192
Abstract

The arotinoid mofarotene is a novel potent anticancer compound. The metabolic profiles obtained from rat, dog, and human plasma showed a good correlation with the corresponding in vitro profiles observed with liver microsomes and hepatocytes. Interspecies differences in its metabolism were investigated using microsomes prepared from the livers of the mouse, rat, dog, cynomolgus monkey, and humans. These in vitro experiments showed that, both qualitatively and quantitatively, the metabolic profiles obtained with cynomolgus monkey liver samples were similar to those observed with human liver material. However, rat and dog were also confirmed to be suitable species for assessing the safety of mofarotene, and were used in toxicology. The involvement of cytochrome P450 (CYP) in the metabolism of mofarotene was examined with human liver microsomes. CYP3A4 plays a major role in the metabolism, and CYP1A2 might be responsible for a minor pathway. Finally, the potential induction by mofarotene of four major CYP isoenzymes was investigated in rats. These experiments showed that CYP1A1 was clearly induced, whereas a slight induction of CYP3A and CYP2B was observed. Repeated administration of mofarotene had no effect on CYP2E1. These studies with liver microsomes and hepatocytes aided the selection of appropriate species for toxicology, and have provided information that will help to predict potential drug-drug interactions in clinical trials.

摘要

芳维甲酸莫法罗汀是一种新型强效抗癌化合物。从大鼠、狗和人血浆中获得的代谢谱与在肝微粒体和肝细胞中观察到的相应体外谱显示出良好的相关性。使用从小鼠、大鼠、狗、食蟹猴和人的肝脏制备的微粒体研究了其代谢的种间差异。这些体外实验表明,无论是定性还是定量,食蟹猴肝脏样品获得的代谢谱与用人肝脏材料观察到的代谢谱相似。然而,大鼠和狗也被证实是评估莫法罗汀安全性的合适物种,并被用于毒理学研究。用人肝脏微粒体研究了细胞色素P450(CYP)在莫法罗汀代谢中的作用。CYP3A4在代谢中起主要作用,CYP1A2可能负责一条次要途径。最后,在大鼠中研究了莫法罗汀对四种主要CYP同工酶的潜在诱导作用。这些实验表明CYP1A1明显被诱导,而观察到CYP3A和CYP2B有轻微诱导。重复给予莫法罗汀对CYP2E1没有影响。这些对肝微粒体和肝细胞的研究有助于选择合适的毒理学研究物种,并提供了有助于预测临床试验中潜在药物相互作用的信息。

相似文献

1
Metabolism of mofarotene in hepatocytes and liver microsomes from different species. Comparison with in vivo data and evaluation of the cytochrome P450 isoenzymes involved in human biotransformation.莫法罗汀在不同物种肝细胞和肝微粒体中的代谢。与体内数据的比较以及对参与人体生物转化的细胞色素P450同工酶的评估。
Drug Metab Dispos. 1995 Oct;23(10):1051-7.
2
Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.新型选择性p38α抑制剂6-(4-(2,5-二氟苯基)恶唑-5-基)-3-异丙基-[1,2,4]-三唑并[4,3-a]吡啶的临床前药代动力学与代谢:在临床前物种及人肝微粒体中活性代谢物的鉴定
Biopharm Drug Dispos. 2006 Nov;27(8):371-86. doi: 10.1002/bdd.520.
3
The In vitro hepatic metabolism of quinine in mice, rats and dogs: comparison with human liver microsomes.奎宁在小鼠、大鼠和犬体内的体外肝脏代谢:与人类肝微粒体的比较。
J Pharmacol Exp Ther. 1997 Dec;283(3):1168-76.
4
Species differences in the toxicity and cytochrome P450 IIIA-dependent metabolism of digitoxin.洋地黄毒苷的毒性及细胞色素P450 IIIA依赖性代谢的种属差异。
Mol Pharmacol. 1991 Nov;40(5):859-67.
5
In vitro hepatic conversion of the anticancer agent nemorubicin to its active metabolite PNU-159682 in mice, rats and dogs: a comparison with human liver microsomes.抗癌药物奈莫柔比星在小鼠、大鼠和犬体内的体外肝脏转化为其活性代谢物PNU - 159682:与人类肝微粒体的比较。
Biochem Pharmacol. 2008 Sep 15;76(6):784-95. doi: 10.1016/j.bcp.2008.07.003. Epub 2008 Jul 11.
6
Hepatic biotransformation of docetaxel (Taxotere) in vitro: involvement of the CYP3A subfamily in humans.多西他赛(泰索帝)在体外的肝脏生物转化:CYP3A亚家族在人体中的作用。
Cancer Res. 1996 Mar 15;56(6):1296-302.
7
Pharmacokinetics and metabolism of a cysteinyl leukotriene-1 receptor antagonist from the heterocyclic chromanol series in rats: in vitro-in vivo correlation, gender-related differences, isoform identification, and comparison with metabolism in human hepatic tissue.大鼠体内杂环色满醇系列半胱氨酰白三烯-1受体拮抗剂的药代动力学与代谢:体外-体内相关性、性别差异、亚型鉴定及与人体肝组织代谢的比较
Drug Metab Dispos. 2001 Nov;29(11):1403-9.
8
The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes.性别、年龄、种族和肝硬化对人肝微粒体中细胞色素P450酶活性及培养的人肝细胞中诱导性的影响。
Toxicol Appl Pharmacol. 2004 Sep 15;199(3):193-209. doi: 10.1016/j.taap.2004.01.010.
9
Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.新型抗微管蛋白剂6-甲氧基-3-(3',4',5'-三甲氧基-苯甲酰基)-1H-吲哚(BPR0L075)在小鼠、大鼠、犬和人肝微粒体中的生物转化。
Drug Metab Dispos. 2007 Jul;35(7):1042-9. doi: 10.1124/dmd.106.014597. Epub 2007 Apr 2.
10
Pharmacokinetics, disposition and lipid-modulating activity of 5-{2-[4-(3,4-difluorophenoxy)-phenyl]-ethylsulfamoyl}-2-methyl-benzoic acid, a potent and subtype-selective peroxisome proliferator-activated receptor alpha agonist in preclinical species and human.5-{2-[4-(3,4-二氟苯氧基)-苯基]-乙基氨磺酰}-2-甲基苯甲酸在临床前物种和人类中的药代动力学、处置及脂质调节活性,一种强效且亚型选择性的过氧化物酶体增殖物激活受体α激动剂
Xenobiotica. 2009 Oct;39(10):766-81. doi: 10.1080/00498250903121796.